ESMO 2023
(EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY)

October 20-24

12:00 PM CET

IFEMA MADRID
Avda. Del Partenón 5, 28042 Madrid, Spain

ESMO 2023: The global stage for oncology experts—clinicians, researchers, advocates, journalists, and industry leaders. Expect the latest data, premier education, and unrivaled networking.

The 'LIVE Plus' Congress offers in-person and virtual attendance from October 20-24, 2023, in Madrid. Connect with peers, engage key opinion leaders, and explore pressing medical oncology topics. Advance your career, collaborate, and enjoy interactive virtual access if you can't attend in person.

Save the date for ESMO 2023, Madrid, Spain, October 20-24, 2023. Join us!

OUR PRESENCE
AT ESMO 2023

MEDSIR at ESMO

Don't miss the video recap of ESMO, featuring our attendance and the presentation of three studies: LUPER, a study on small cell lung cancer, and two translational studies from PHERGain trial.

Interview with Dr. Javier Cortés at ESMO

Dr. Cortés highlighted the MEDSIR's ESMO congress, emphasizing the importance of translational studies within the PHERGain trial.

ABSTRACTS & PRESENTATIONS

Find out the three studies we are showcasing at this year's ESMO conference. We invite you to explore them in detail and discover the latest advancements in our field.

In this scenario, and after the successful presentation of the PHERgain trial results at the ASCO 2023 congress held in Chicago, MEDSIR will actively participate in the ESMO congress with a mini-oral presentation of the LUPER study (lung cancer) and two poster-format from translational studies that expand upon the results of PHERGain Trial.

Screen Shot 2023-09-07 at 10.33.55 (2).png

TROP-2 A sub analysis of PHERGain trial ESMO 2023.png

COME AND JOIN US!

We are thrilled to invite you to be a part of our journey as we dive into the world of oncology excellence at the European Society for Medical Oncology (ESMO) congress. Our team is geared up to embrace the latest advancements, connect with industry leaders, and share the cutting-edge insights that define our commitment to healthcare innovation.